Disease_category,Disease,Protein,Protein_definition,Method,Nb_SNP,OR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,13,1.33 [1.20-1.48],1.28956534097005e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,MFGE8,Lactadherin,Inverse variance weighted,26,1.08 [1.00-1.15],0.0356052141854932
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,24,0.94 [0.89-0.98],0.008974740044115
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,CTSD,Cathepsin D,Inverse variance weighted,24,1.04 [1.01-1.08],0.019298185705746
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,CPE,Carboxypeptidase E,Inverse variance weighted,16,0.92 [0.88-0.96],0.0003646268436174
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,AGRN,Agrin,Inverse variance weighted,31,0.96 [0.92-1.00],0.0449968397905877
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,DMP1,Dentin matrix acidic phosphoprotein 1,Inverse variance weighted,17,0.93 [0.87-0.98],0.0134803776741387
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,SEMA3G,Semaphorin-3G,Inverse variance weighted,66,1.04 [1.01-1.07],0.003966378601694
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,25,1.04 [1.01-1.06],0.0125882917664208
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,ANXA10,Annexin A10,Wald ratio,1,1.45 [1.11-1.89],0.0064424643710772
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,41,1.04 [1.01-1.08],0.0176190162451587
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,LGALS4,Galectin-4,Inverse variance weighted,19,0.94 [0.90-0.97],0.0006693187288455
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,17,0.94 [0.88-0.99],0.0287032886349939
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,23,0.92 [0.87-0.98],0.0127744027613481
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,Wald ratio,1,0.14 [0.10-0.20],3.22836239374649e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,3,0.92 [0.85-0.99],0.0285452327799906
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,ADIPOQ,Adiponectin,Inverse variance weighted,37,0.95 [0.91-1.00],0.038261768506087
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,14,0.92 [0.86-0.98],0.0077357176938604
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,LPA,Apolipoprotein(a),Inverse variance weighted,46,1.06 [1.04-1.09],1.37555782518291e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.96 [0.94-0.99],0.0064225232399601
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,LETM1,Mitochondrial proton/calcium exchanger protein,Inverse variance weighted,2,0.75 [0.61-0.92],0.0070571400103464
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,12,0.84 [0.75-0.96],0.0072253111902733
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,21,1.54 [1.23-1.93],0.000137990695587
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,HYAL1,Hyaluronidase-1,Inverse variance weighted,23,1.04 [1.00-1.08],0.0253803736016028
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,76,0.99 [0.98-1.00],0.0230372823405771
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,30,0.96 [0.92-1.00],0.033187087481097
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,CLSTN2,Calsyntenin-2,Inverse variance weighted,38,0.97 [0.95-1.00],0.0359105784305034
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,GM2A,Ganglioside GM2 activator,Inverse variance weighted,26,1.02 [1.00-1.05],0.0415870751886752
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Inverse variance weighted,22,0.86 [0.83-0.89],4.04022318658841e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,IL6,Interleukin-6,Inverse variance weighted,6,0.93 [0.88-0.99],0.025892267386844
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,3,0.86 [0.75-0.98],0.0256976608855588
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,16,1.08 [1.00-1.15],0.0358077102220678
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,PTPRR,Receptor-type tyrosine-protein phosphatase R,Inverse variance weighted,5,0.88 [0.78-0.99],0.0346454845605077
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,Inverse variance weighted,24,1.07 [1.03-1.11],0.0003640023527068
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,PRSS2,Trypsin-2,Inverse variance weighted,22,0.93 [0.87-1.00],0.0438431432756795
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,FGF5,Fibroblast growth factor 5,Inverse variance weighted,43,1.02 [1.00-1.05],0.0437374097821064
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,19,1.05 [1.01-1.10],0.0174239560615998
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Inverse variance weighted,7,0.86 [0.76-0.97],0.0121030189823353
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,49,1.04 [1.01-1.07],0.0043767687447665
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,6,0.93 [0.88-0.99],0.020618848731691
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,28,0.98 [0.96-1.00],0.0292255746353451
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,SERPIND1,Heparin cofactor 2,Inverse variance weighted,35,0.91 [0.85-0.98],0.0117976574374473
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,PSIP1,PC4 and SFRS1-interacting protein,Wald ratio,1,0.70 [0.50-0.98],0.0359208777324494
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,KHK,Ketohexokinase,Inverse variance weighted,26,1.06 [1.02-1.10],0.0008862934637119
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,SFTPD,Pulmonary surfactant-associated protein D,Inverse variance weighted,54,1.02 [1.00-1.04],0.0299231050616585
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,GRN,Progranulin,Inverse variance weighted,46,1.09 [1.06-1.13],3.71336997799023e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1.45 [1.04-2.02],0.027347102329743
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.93 [0.87-1.00],0.0485983925114957
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,GPKOW,G-patch domain and KOW motifs-containing protein,Inverse variance weighted,2,1.29 [1.06-1.58],0.0113668272964418
"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,1.06 [1.02-1.09],0.0006434808562688
